Moon Pharmaceuticals

Moon Pharmaceuticals is located in Las Vegas, United States on 6092 St Petersburg Dr. Moon Pharmaceuticals is rated 3 out of 5 in the category end disease today. in United States. Moon Pharmaceuticals is a startup cannabinoid biotech focused on CB2/ECS research and product commercialization. Our simple mission is to end disease today. We are currently seeking seed investors/strategic partners for full roll-out and commercialization of our non-psychoactive CB2 proprietary formulations product line. We are extracting (ECS/CB2-specific agonists) cannabinoids from plants that are NOT cannabis or hemp to create formulations that have similar health benefits and effects. Because none of our products contain cannabis and therefore THC, our products can support your health in the same way as cannabis can, but without the psychoactive effects. Plus: 30 times less cost ($49.99 @30,000 mg of CB2 cannabinoids) compared to CBD/cannabis products like the FDA-approved Epidiolex ($24080 @100,000 mg of CB3 cannabinoids) and otc-legal worldwide today without needing a prescription. "The recent discovery of different plants with compounds that modulate the Endocannabinoid System (ECS) means we can no longer simply define plant cannabinoids as merely a product of cannabis/hemp." -Prof. Roger Pertwee, GW Pharmaceuticals (maker of FDA-approved CBD prescription medicine, Epidiolex) "Changes in endocannabinoid levels and/or CB2 receptor expressions have been reported in almost ALL diseases affecting humans, ranging from cardiovascular, gastrointestinal, liver, kidney, neurodegenerative, psychiatric, bone, skin, auto-immune, lung disorders to pain and cancer, and modulating CB2 receptor activity holds TREMENDOUS therapeutic potential in these pathologies." -Prof Raphael Mechoulam/Grandfather of Cannabinoid Research Note: CBD does NOT activate the CB2 receptor as many wrongly believe, but instead activates the newly discovered CB3 receptor and other receptors of the constantly evolving Endocannabinoid System.